NCT06332521

Brief Summary

Crying is a vital communication signal for the baby. Product of a complex physiological process, it reflects not only the organization and functioning of the cortical central nervous system and the function of sympathetic and parasympathetic autonomic regulation but also the integrity of three entities: the lungs responsible for ventilatory mechanics and respiratory rhythm, the larynx and its vocal cords as a phonatory organ, and the oropharyngeal tract guaranteeing the resonance of the sound emitted by the vocal cords. Crying is usually caused by pain, discomfort, hunger, or separation from parents or other caregivers. Crying carries essential information from birth, the expression of which depends closely on the neuroanatomical and functional brain integrity of the child. On a bioacoustic level, crying consists of sequences of complex acoustic signals produced by the vocal folds and filtered by the vocal tract. The vibration frequency of the vocal cords determines the cry's fundamental frequency f0 (and the harmonic frequencies), which is responsible for its more or less low or high pitch. Other acoustic cues also characterize each baby's cry.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,100

participants targeted

Target at P75+ for all trials

Timeline
22mo left

Started Mar 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Mar 2024Mar 2028

First Submitted

Initial submission to the registry

March 20, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

March 20, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 27, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

4 years

First QC Date

March 20, 2024

Last Update Submit

May 22, 2025

Conditions

Keywords

NewbornCrying

Outcome Measures

Primary Outcomes (2)

  • Fundamental frequency f0 (Hz)

    Fundamental frequency f0 (Hz) defined from a crying sequence, the most characteristic elementary index of their individual bioacoustic signature.

    At inclusion

  • Bailey-4 quantitative scale

    neurodevelopment at age 2 measured by the Bailey-4 quantitative scale. The final score is from 40 (Very weak neurodevelopment) to 160 (Very good neurodevelopment)

    At 2 years

Secondary Outcomes (7)

  • Percentage voiced frames

    At inclusion

  • Harmonics of f0 (Hz)

    At inclusion

  • Median pitch f0 (Hz)

    At inclusion

  • Harmonicity (dB)

    At inclusion

  • Jitter (Percentage),

    At inclusion

  • +2 more secondary outcomes

Study Arms (2)

birth of term babies

Study of crying in a group of newborns (birth of term babies)

Other: Acoustic signal analysis method

Premature babies

Study of crying in a group of newborns (Premature babies )

Other: Acoustic signal analysis method

Interventions

Evaluate at birth in 2 characterized populations of babies born at term or prematurely, the correlation between bioacoustic characteristic of a cry specific to each baby, with the neurodevelopmental data at 2 years.

Premature babiesbirth of term babies

Eligibility Criteria

AgeUp to 4 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Full-term baby \> 37 weeks Premature baby \< 37 weeks

You may qualify if:

  • For a full-term baby \> 37 weeks
  • For a premature baby \< 37 weeks
  • Born in the maternity ward of the Saint-Etienne University Hospital
  • Holder of parental authority having received informed information about the study and their right to object
  • Holder of parental authority affiliated to or beneficiary of a social security system
  • Eutrophic between the 10th and 90th percentile on the neonatal curves)

You may not qualify if:

  • Refusal of participation by the holder of parental authority
  • Antenatal pathology, nor perinatal asphyxia
  • Holder of minor parental authority
  • Holder of parental authority under curatorship or guardianship
  • Abnormal T1 audiological screening test.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu de Saint-Etienne

Saint-Etienne, 42055, France

RECRUITING

MeSH Terms

Conditions

Premature BirthCrying

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesNonverbal CommunicationCommunicationBehavior

Study Officials

  • HUGUES PATURAL, MD-PhD

    CHU DE SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR
  • Nicolas MATHEVON, PhD

    Saint-Etienne University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2024

First Posted

March 27, 2024

Study Start

March 20, 2024

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

March 1, 2028

Last Updated

May 28, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations